136 related articles for article (PubMed ID: 38105682)
41. Dense GM-CSFR
Saranaruk P; Waraasawapati S; Chamgramol Y; Sawanyawisuth K; Paungpan N; Somphud N; Wongkham C; Okada S; Wongkham S; Vaeteewoottacharn K
PeerJ; 2023; 11():e14883. PubMed ID: 36883059
[TBL] [Abstract][Full Text] [Related]
42. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
[TBL] [Abstract][Full Text] [Related]
43. Analysis of transcriptome in the relationship between expression of PRC1 protein and prognosis of patients with cholangiocarcinoma.
Wang Q; Lu S; Chen Y; He H; Lu W; Lin K
J Int Med Res; 2021 Mar; 49(3):300060521989200. PubMed ID: 33706578
[TBL] [Abstract][Full Text] [Related]
44. [Clinical value of nomogram model in evaluating the prognosis of cholangiocarcinoma after interventional therapy].
Li Z; Xie BC; Lyu PJ; Wang HX; Li Y; Wang CH; Li X; Ye SW; Li G; Pang PF; Zhang YY; Yu P
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1217-1224. PubMed ID: 37087405
[No Abstract] [Full Text] [Related]
45. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
46. Expressional and prognostic value of HPCAL1 in cholangiocarcinoma via integrated bioinformatics analyses and experiments.
Ma M; Zeng G; Li J; Liang J; Huang L; Chen J; Lai J
Cancer Med; 2023 Jan; 12(1):824-836. PubMed ID: 35645147
[TBL] [Abstract][Full Text] [Related]
47. Preoperative Survival Prediction in Intrahepatic Cholangiocarcinoma Using an Ultrasound-Based Radiographic-Radiomics Signature.
Li MD; Lu XZ; Liu JF; Chen B; Xu M; Xie XY; Lu MD; Kuang M; Wang W; Shen SL; Chen LD
J Ultrasound Med; 2022 Jun; 41(6):1483-1495. PubMed ID: 34549829
[TBL] [Abstract][Full Text] [Related]
48. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study.
Cao XM; Kang WD; Xia TH; Yuan SB; Guo CA; Wang WJ; Liu HB
World J Gastroenterol; 2023 Jun; 29(23):3645-3657. PubMed ID: 37398880
[TBL] [Abstract][Full Text] [Related]
49. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
[TBL] [Abstract][Full Text] [Related]
50. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
51. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
52. Development and validation of a nomogram to predict cancer-specific survival with unresected cholangiocarcinoma undergoing external radiotherapy.
Song J; Di Y; Kang X; Ren G; Wang Y
Front Public Health; 2023; 11():1012069. PubMed ID: 36817916
[TBL] [Abstract][Full Text] [Related]
53. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
Park HJ; Park B; Park SY; Choi SH; Rhee H; Park JH; Cho ES; Yeom SK; Park S; Park MS; Lee SS
Eur Radiol; 2021 Nov; 31(11):8638-8648. PubMed ID: 33890153
[TBL] [Abstract][Full Text] [Related]
54. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
Jiao CY; Zhang H; Ji GW; Xu Q; Lu M; Zhang B; Yang Y; Wang XH; Li XC
Eur Radiol; 2022 Dec; 32(12):8326-8338. PubMed ID: 35708837
[TBL] [Abstract][Full Text] [Related]
55. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
Cui J; Jiang H
Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
[TBL] [Abstract][Full Text] [Related]
56. Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma.
Kang SH; Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
J Hepatobiliary Pancreat Sci; 2018 Apr; 25(4):240-248. PubMed ID: 29450978
[TBL] [Abstract][Full Text] [Related]
57. A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma.
Fu J; Chen Q; Lai Z; Lin K; Fang G; Ding Z; Gao Y; Zeng Y
BMC Cancer; 2023 Feb; 23(1):188. PubMed ID: 36829168
[TBL] [Abstract][Full Text] [Related]
58. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma.
Sae-Fung A; Mutirangura A; Jitkaew S
Front Immunol; 2022; 13():1051273. PubMed ID: 36733386
[TBL] [Abstract][Full Text] [Related]
59. Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging system.
Hahn F; Müller L; Mähringer-Kunz A; Schotten S; Düber C; Hinrichs JB; Maschke SK; Galle PR; Bartsch F; Lang H; Weinmann A; Kloeckner R
PLoS One; 2020; 15(2):e0228501. PubMed ID: 32012198
[TBL] [Abstract][Full Text] [Related]
60. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]